D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.27% |
| 2 | Consumer Discretionary | 9.91% |
| 3 | Healthcare | 7.11% |
| 4 | Financials | 6.94% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRA
3551
DELISTED
ProAssurance
PRA
| $883K | ﹤0.01% |
37,114
-30,092
| -45% | -$693K |
|
|
NMTR
3552
DELISTED
9 Meters Biopharma
NMTR
| $882K | ﹤0.01% |
33,929
-645
| -2% | -$15.2K |
|
|
DHC
3553
Diversified Healthcare Trust
DHC
$2.28B
| $881K | ﹤0.01% |
259,979
-165,924
| -39% | -$626K |
|
3554
United Natural Foods
UNFI
$3.07B
| $881K | ﹤0.01% |
+18,205
| New | +$644K |
|
3555
Alector
ALEC
$169M
| $880K | ﹤0.01% |
38,548
+471
| +1% | +$13.2K |
|
|
WW
3556
PUT
DELISTED
WW International
WW
| $880K | ﹤0.01% |
+48,200
| New | +$1.26M |
|
|
PLMJU
3557
DELISTED
Plum Acquisition Corp. III Unit
PLMJU
| $880K | ﹤0.01% |
+89,001
| New | +$883K |
|
|
ALLK
3558
DELISTED
Allakos
ALLK
| $877K | ﹤0.01% |
8,287
-79,099
| -91% | -$7.07M |
|
|
HOUS
3559
CALL
DELISTED
Anywhere Real Estate
HOUS
| $877K | ﹤0.01% |
+50,000
| New | +$881K |
|
3560
TriNet
TNET
$3.14B
| $876K | ﹤0.01% |
+9,266
| New | +$794K |
|
|
LENZ
3561
LENZ Therapeutics
LENZ
$184M
| $876K | ﹤0.01% |
+7,639
| New | +$1.13M |
|
3562
CALL
PTC
PTC
$14.7B
| $874K | ﹤0.01% |
7,300
| – | – |
|
3563
Horizon Bancorp
HBNC
$1.06B
| $872K | ﹤0.01% |
48,003
-1,434
| -3% | -$24.8K |
|
3564
Xencor
XNCR
$1.48B
| $871K | ﹤0.01% |
26,670
-18,966
| -42% | -$623K |
|
3565
CALL
Beam Therapeutics
BEAM
$2.7B
| $870K | ﹤0.01% |
10,000
| – | – |
|
3566
PUT
The RealReal
REAL
$1.44B
| $870K | ﹤0.01% |
66,000
+26,000
| +65% | +$385K |
|
3567
UMB Financial
UMBF
$10.9B
| $870K | ﹤0.01% |
9,000
+3,879
| +76% | +$354K |
|
|
TPIC
3568
DELISTED
TPI Composites
TPIC
| $869K | ﹤0.01% |
+25,758
| New | +$1.01M |
|
3569
PUT
Boston Scientific
BSX
$68.5B
| $868K | ﹤0.01% |
20,000
| – | – |
|
3570
Center Bancorp
CNOB
$1.66B
| $868K | ﹤0.01% |
28,910
-15,832
| -35% | -$438K |
|
3571
Live Nation Entertainment
LYV
$42.1B
| $868K | ﹤0.01% |
9,528
-2,525
| -21% | -$213K |
|
|
UHT
3572
Universal Health Realty Income Trust
UHT
$628M
| $864K | ﹤0.01% |
15,631
+5,694
| +57% | +$335K |
|
|
ADOC
3573
DELISTED
Edoc Acquisition Corp. Class A Ordinary Share
ADOC
| $861K | ﹤0.01% |
84,956
| – | – |
|
3574
Red Robin
RRGB
$139M
| $859K | ﹤0.01% |
+37,238
| New | +$959K |
|
3575
Simon Property Group
SPG
$76.8B
| $858K | ﹤0.01% |
+6,600
| New | +$859K |
|
Similar funds
D.E. Shaw & Co's Q3 2021 Portfolio in Review
As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.
- D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
- D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.